SAB BIOTHERAPEUTICS INC's ticker is and the CUSIP is 78397T103. A total of 38 filers reported holding SAB BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,165 | -24.1% | 52,643 | 0.0% | 0.00% | – |
| Q2 2023 | $43,694 | -9.7% | 52,643 | -52.1% | 0.00% | – |
| Q1 2023 | $48,406 | -24.1% | 110,013 | +1.7% | 0.00% | – |
| Q4 2022 | $63,799 | -27.5% | 108,153 | -14.0% | 0.00% | – |
| Q3 2022 | $88,000 | -52.4% | 125,722 | -1.4% | 0.00% | – |
| Q2 2022 | $185,000 | -32.2% | 127,446 | +75.7% | 0.00% | – |
| Q1 2022 | $273,000 | -51.2% | 72,518 | +1.3% | 0.00% | – |
| Q4 2021 | $559,000 | – | 71,608 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First PREMIER Bank | 807,535 | $476 | 0.14% |
| Warberg Asset Management LLC | 370,370 | $218,518 | 0.03% |
| METEORA CAPITAL, LLC | 134,524 | $79,356 | 0.02% |
| INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC | 149,774 | $88,352 | 0.02% |
| SILVER OAK SECURITIES, INCORPORATED | 51,941 | $31 | 0.01% |
| Veritable, L.P. | 506,513 | $298,792 | 0.01% |
| Shaolin Capital Management LLC | 236,621 | $140 | 0.00% |
| Elgethun Capital Management | 14,796 | $9,171 | 0.00% |
| LGL PARTNERS, LLC | 23,000 | $13,568 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 84,000 | $49,552 | 0.00% |